<DOC>
	<DOCNO>NCT00259103</DOCNO>
	<brief_summary>The purpose study assess safety efficacy rhRlx cervical ripening , compare placebo .</brief_summary>
	<brief_title>Recombinant Human Relaxin ( rhRlx ) Pregnant Women Scheduled Induction Labor</brief_title>
	<detailed_description>A multicenter , randomize , double-blind , placebo-controlled , dose escalation study healthy female subject â‰¥ 40 week gestation schedule induction . A dose-escalation portion study follow randomize , double-blind , placebo-controlled portion study . The endpoint include cervical ripening , well progression labor delivery .</detailed_description>
	<mesh_term>Methocarbamol</mesh_term>
	<criteria>Age 18 40 year Normal pregnancy At least 40 week gestation Otherwise healthy Anemia hypertension Presence chronic disease Endometriosis Known fetal anomaly Substance abuse History cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>relaxin</keyword>
	<keyword>pregnancy</keyword>
	<keyword>cervical ripening</keyword>
	<keyword>normal pregnancy least 40 week gestation</keyword>
</DOC>